Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × ASP3662 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

Cyclophosphamide 2741 Cisplatin 2715 Carboplatin 2518 Radiotherapy 2327 Paclitaxel 2308 Gemcitabine 2174 pembrolizumab 1998 Docetaxel 1888 Bevacizumab 1828 Fluorouracil 1581 Capecitabine 1556 Oxaliplatin 1470 Dexamethasone 1366 Nivolumab 1292 Doxorubicin 1280 Rituximab 1262 Etoposide 1160 Magnetic Resonance Spectroscopy 1090 Irinotecan 1066 Leucovorin 1052 Cytarabine 987 Drug Therapy 913 fludarabine 912 Pemetrexed 901 Vincristine 816 Lenalidomide 800 Prednisone 798 Cetuximab 787 Specimen Handling 783 Filgrastim 783

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296484 2026-02-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡